S453-0317 Screening compound: 4-({2,4-dioxo-8-oxa-1,3-diazaspiro[4.5]decan-3-yl}methyl)-N-(2-phenylethyl)benzamide

S453-0317 Screening compound: 4-({2,4-dioxo-8-oxa-1,3-diazaspiro[4.5]decan-3-yl}methyl)-N-(2-phenylethyl)benzamide
S453-0317 Screening compound: 4-({2,4-dioxo-8-oxa-1,3-diazaspiro[4.5]decan-3-yl}methyl)-N-(2-phenylethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S453-0317
4-({2,4-dioxo-8-oxa-1,3-diazaspiro[4.5]decan-3-yl}methyl)-N-(2-phenylethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S453-0317

Molecular Formula

C23H25N3O4 (C23 H25 N3 O4)

Compound Name

4-({2,4-dioxo-8-oxa-1,3-diazaspiro[4.5]decan-3-yl}methyl)-N-(2-phenylethyl)benzamide

IUPAC name

4-({24-dioxo-8-oxa-13-diazaspiro[4.5]decan-3-yl}methyl)-N-(2-phenylethyl)benzamide

SMILES

O=C(c1ccc(CN(C(C2(CCOCC2)N2)=O)C2=O)cc1)NCCc1ccccc1

InChI

InChI=1S/C23H25N3O4/c27-20(24-13-10-17-4-2-1-3-5-17)19-8-6-18(7-9-19)16-26-21(28)23(25-22(26)29)11-14-30-15-12-23/h1-9H,10-16H2,(H,24,27)(H,25,29)

InChI Key

JVXKUHIOSXNVSY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29007681

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.030

Distribution Coefficient, logD

2.030

Water Solubility, LogSw

-2.64

Polar Surface Area

74.001

Acid Dissociation Constant (pKa)

12.01

Base Dissociation Constant (pKb)

-2.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

S453-0317 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

SH2 Library (10483 compounds)

Spiro Library (21655 compounds)

Antibacterial Compounds Library (13827 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Endocrine
  • Infections
  • Immune system
  • animal
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S453-0317 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S453-0317?
Check Price and Availability of S453-0317, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S453-0317 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S453-0317
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S453-0317
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S453-0317 available by request